Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " July 29, 2009":" August 28, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" July 29, 2009":" August 28, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (33 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
2 Completed Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men
Condition: HIV Infections
Interventions: Behavioral: Referral of Partners;   Behavioral: Screening for STIs and counseling;   Behavioral: Peer health care system navigators;   Behavioral: Enhanced counseling
3 Unknown  Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)
Condition: HIV Infections
Intervention: Drug: Adaptavir (monomeric DAPTA)
4 Completed IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
Condition: HIV Infection
Intervention: Drug: Highly active antiretroviral therapy (HAART)
5 Completed Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Condition: HIV Infections
Interventions: Drug: fosamprenavir/ritonavir;   Drug: olanzapine
6 Enrolling by invitation Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Keep It Up!;   Behavioral: Information only
7 Completed Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults
Condition: HIV Infections
Interventions: Biological: NYVAC-B;   Biological: Placebo;   Biological: rAd5
8 Unknown  Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
Conditions: HIV Transmission;   HIV Infections
Intervention: Drug: tenofovir + emtricitabine, lopinavir/ritonavir
9 Unknown  Reducing HIV Risks in African American Teens
Condition: HIV Infections
Intervention: Behavioral: Healthy Futures parent education
10 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
11 Completed Evaluating the Pharmacokinetics of 400 mg Oral Dose of Raltegravir in HIV-Infected Pre-Menopausal Women
Condition: HIV Infections
Intervention:
12 Completed Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: control group
13 Completed Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load
Condition: HIV Infections
Intervention:
14 Completed Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
Condition: HIV Infections
Intervention:
15 Unknown  Genotypic Resistant HIV Strains in Taiwan
Conditions: HIV-1;   HIV Infections
Intervention:
16 Completed Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.
Condition: HIV Infections
Intervention: Drug: bevirimat dimeglumine
17 Completed Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
18 Completed
Has Results
Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
Condition: HIV Infections
Interventions: Drug: Etravirine (Intelence);   Drug: Truvada
19 Withdrawn Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts
Conditions: HIV Infection;   AIDS;   HIV Infections
Intervention:
20 Completed CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Lopinavir/Ritonavir plus Lamivudine/Zidovudine;   Drug: Efavirenz plus Lamivudine/Zidovudine

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.